Universities and research institutes at TIDES Europe 2026

Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website

12 universities and research institutes are at TIDES Europe 2026 — 15 presentations on the program. Most represented: University of KwaZulu-Natal (2 on the program), University of Southampton (2 on the program), University of Queensland (1 on the program). 3 of them have their own page in this guide. As of Sep 25, 2026.

All 160 organizations at TIDES Europe 2026 →

Showing 1–12 of 12 organizations

Organization	TIDES Europe 2026 Attendance
University of KwaZulu-Natal Durban, South Africa
	Talk Tue Nov 3 09:35–10:05 A Symmetrical Alternative to Lysine-core Based Branched Peptides A symmetrical chemical hub for building branched peptides so that synthesis errors produce one predictable impurity instead of a mixture. Talk Thu Nov 5 10:15–10:45 Sustainability in Peptide Manufacturing Replacing the solvents, resins and acids that make standard peptide synthesis wasteful, and how solid-support and solution methods compare.
University of Southampton Southampton, United Kingdom
	Talk Wed Nov 4 08:35–09:05 Identification of Cyclic Peptides Synthetically Lethal to MTAP Deletion Cancer Cells through High Throughput Phenotypic Screening Screening millions of ring-shaped peptides inside cells found one that kills cancer cells lacking a certain metabolic gene by acting on RNA-processing enzymes. Talk Thu Nov 5 14:00–14:30 Neutral Backbones and Dendrons for Enhanced Therapeutic Oligonucleotides Delivery Charge-neutral replacements for the DNA backbone, paired with branched carriers, that resist enzymes and help oligonucleotides get inside cells.
University of Queensland Brisbane, Australia
	Talk Wed Nov 4 08:00–08:05 Chairman’s Remarks: Innovations in Peptide Discovery Peptide Discovery to CMC Talk Wed Nov 4 10:45–11:15 Cyclisation of the Analgesic α-conotoxin Vc1.1 with a Non-natural Linker to Improve Biopharmaceutical Properties Reshaping a cone snail peptide for nerve pain into a ring with a synthetic linker, to keep it stable and active when swallowed.
EPFL Lausanne, Switzerland
epfl.ch Academic Swiss federal technology institute conducting research in chemistry, life sciences and engineering.	Talk Thu Nov 5 08:05–08:35 High-throughput Synthesis and Screening of > 80,000 Peptidic Compounds with Covalent Warheads Making about 85,000 short peptides that each carry a reactive group, then screening them for ones that bind a protein permanently.
Erasmus MC Rotterdam, Netherlands
erasmusmc.nl Academic University medical center combining patient care, education and biomedical research.	Talk Fri Nov 6 14:30–14:45 Presentation: Translational Medicine at the Crossroads of Obesity and Type 2 Diabetes: From Disease Mechanisms to Precision Therapeutics Post-event symposium: Technology and Process Innovation Spotlight
ETH Zurich Zurich, Switzerland
ethz.ch Academic Swiss federal technology university conducting research in chemistry, pharmaceutical sciences and engineering.	Talk Wed Nov 4 09:05–09:35 Targeting Fibrotic Tissue for Peptide-based Diagnostic and Therapeutic Applications A new way to aim peptide drugs and imaging agents at scarred tissue, the hard-to-reach hallmark of many long-term diseases.
RU RCSI University of Medicine and Health Sciences Dublin, Ireland
	Talk Fri Nov 6 13:45–14:00 Presentation: Investigating FKBPL as an Emerging Metabolic Target in Obesity Post-event symposium: Technology and Process Innovation Spotlight
SM Sheba Medical Center Ramat Gan, Israel
	Talk Thu Nov 5 17:00–17:30 Overcoming the Cost Bottleneck in N=1 Therapeutics: A Highly Affordable, GMP-Compliant CMC Platform for Rapid Clinical Deployment A cheaper, standardised way to make a one-patient antisense drug under regulated manufacturing rules, used for a child with a rare brain disorder.
Sorbonne Université Paris, France
	Talk Thu Nov 5 17:00–17:30 Breaking New Ground in PRRT: CD47-Targeting Cyclic Peptides with Next-Generation Pyclen Chelators Cyclic peptides with new metal-holding cages, designed to carry radioactive metals to a protein found on hard-to-treat tumours.
TU Wien Vienna, Austria
	Talk Wed Nov 4 10:15–10:45 Posttranslational Modifications in Peptide Design and Activity How chemical tags added after a peptide is made change its folding, stability and activity, studied in small natural toxin peptides.
University of Amsterdam Amsterdam, Netherlands
	Talk Thu Nov 5 17:00–17:30 LC-MS Innovation for Impurity Profiling of Oligonucleotide Therapeutics: Ion-Pair Hydrophilic Interaction Chromatography (HILIC) and FOCUS Two-Dimensional LC (2DLC) MS Methods A two-stage liquid chromatography setup that pulls apart same-length oligonucleotide impurities which normally hide under the main product peak.
University of Würzburg Würzburg, Germany
	Keynote Tue Nov 3 15:50–16:25 New Concepts in Nucleic Acid Chemistry for Site-specific Modification of RNA by Ribozymes and Chemically Modified Nucleic Acid Catalysts Newly found ribozymes, RNA molecules that cut or tag other RNA, and chemical tweaks that keep them active inside cells. OligonucleotidesDiscovery & Clinical